Literature DB >> 1495991

Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins.

S T Kunitake1, M R Jarvis, R L Hamilton, J P Kane.   

Abstract

We have found transition metals tightly bound to apolipoprotein A-I-containing lipoproteins [Lp(A-I)] isolated by selected affinity immunosorption from human serum. Prominent among the metal ions detected were iron and copper. By immunoblotting the proteins of Lp(A-I), we detected both transferrin and ceruloplasmin. The transferrin-containing Lp(A-I) particles, isolated by selected affinity immunosorption against transferrin, were larger (mean diameter of 14.2 nm) and had a higher protein content than most high density lipoproteins (HDL). Ultracentrifugally isolated HDL were found to contain much less transferrin, whereas transferrin was found associated with apolipoprotein A-I from the greater than 1.21-g/ml ultracentrifugal fraction. This suggests that the complex is not recovered in the classic HDL density interval because of its very high density. HDL inhibit copper-catalyzed oxidation of low density lipoproteins (LDL) in vitro. We have found that immunoisolated Lp(A-I) are an order of magnitude more effective in inhibiting the oxidation of LDL than ultracentrifugally isolated HDL, on the basis of protein mass. When the Lp(A-I) particles containing transferrin and ceruloplasmin were removed from the bulk of Lp(A-I), inhibition of the in vitro oxidation of LDL was significantly decreased.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1495991      PMCID: PMC49631          DOI: 10.1073/pnas.89.15.6993

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Evidence for an essential role for high-density lipoprotein in progesterone synthesis by rat corpus luteum.

Authors:  B C McNamara; R Booth; D A Stansfield
Journal:  FEBS Lett       Date:  1981-11-02       Impact factor: 4.124

2.  Binding of high density lipoprotein to human fetal adrenal membrane fractions.

Authors:  M Ohashi; B R Carr; E R Simpson
Journal:  Endocrinology       Date:  1981-09       Impact factor: 4.736

3.  Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor VIIa and tissue factor.

Authors:  S D Carson
Journal:  FEBS Lett       Date:  1981-09-14       Impact factor: 4.124

4.  Factors affecting the integrity of high density lipoproteins in the ultracentrifuge.

Authors:  S T Kunitake; J P Kane
Journal:  J Lipid Res       Date:  1982-08       Impact factor: 5.922

Review 5.  Cholesterol transport between cells and body fluids. Role of plasma lipoproteins and the plasma cholesterol esterification system.

Authors:  C J Fielding; P E Fielding
Journal:  Med Clin North Am       Date:  1982-03       Impact factor: 5.456

6.  Characterization of human high-density lipoproteins by gradient gel electrophoresis.

Authors:  P J Blanche; E L Gong; T M Forte; A V Nichols
Journal:  Biochim Biophys Acta       Date:  1981-09-24

7.  Direct determination of plasma copper and zinc in infants by atomic absorption with discrete nebulization.

Authors:  T Makino; K Takahara
Journal:  Clin Chem       Date:  1981-08       Impact factor: 8.327

8.  Disc-electrophoretic patterns of human serum high density lipoproteins.

Authors:  G Utermann
Journal:  Clin Chim Acta       Date:  1972-02       Impact factor: 3.786

9.  Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II.

Authors:  M C Cheung; J J Albers
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

10.  Apolipoproteins as the basis for heterogeneity in high-density lipoprotein2 and high-density lipoprotein3. Studies by isoelectric focusing on agarose films.

Authors:  Y L Marcel; P K Weech; T D Nguyen; R W Milne; W J McConathy
Journal:  Eur J Biochem       Date:  1984-09-17
View more
  23 in total

1.  Oxidative modification and poor protective activity of HDL on LDL oxidation in thalassemia.

Authors:  Supeenun Unchern; Narumon Laohareungpanya; Yupin Sanvarinda; Kovit Pattanapanyasat; Pansakorn Tanratana; Udom Chantharaksri; Nathawut Sibmooh
Journal:  Lipids       Date:  2010-06-09       Impact factor: 1.880

2.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

Authors:  Tomas Vaisar; Subramaniam Pennathur; Pattie S Green; Sina A Gharib; Andrew N Hoofnagle; Marian C Cheung; Jaeman Byun; Simona Vuletic; Sean Kassim; Pragya Singh; Helen Chea; Robert H Knopp; John Brunzell; Randolph Geary; Alan Chait; Xue-Qiao Zhao; Keith Elkon; Santica Marcovina; Paul Ridker; John F Oram; Jay W Heinecke
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

Review 3.  Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches.

Authors:  Emil M deGoma; Rolando L deGoma; Daniel J Rader
Journal:  J Am Coll Cardiol       Date:  2008-06-10       Impact factor: 24.094

Review 4.  High-density lipoprotein and atherosclerosis: the role of antioxidant activity.

Authors:  Salman Bandeali; John Farmer
Journal:  Curr Atheroscler Rep       Date:  2012-04       Impact factor: 5.113

Review 5.  Alterations in lipoprotein defense against oxidative stress in metabolic syndrome.

Authors:  Boris Hansel; Anatol Kontush; Dominique Bonnefont-Rousselot; Eric Bruckert; M John Chapman
Journal:  Curr Atheroscler Rep       Date:  2006-11       Impact factor: 5.113

6.  Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins.

Authors:  E Dimitriadis; M Griffin; P Collins; A Johnson; D Owens; G H Tomkin
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

7.  Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.

Authors:  D S Ng; L A Leiter; C Vezina; P W Connelly; R A Hegele
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

8.  Serum amyloid A impairs the antiinflammatory properties of HDL.

Authors:  Chang Yeop Han; Chongren Tang; Myriam E Guevara; Hao Wei; Tomasz Wietecha; Baohai Shao; Savitha Subramanian; Mohamed Omer; Shari Wang; Kevin D O'Brien; Santica M Marcovina; Thomas N Wight; Tomas Vaisar; Maria C de Beer; Frederick C de Beer; William R Osborne; Keith B Elkon; Alan Chait
Journal:  J Clin Invest       Date:  2015-12-07       Impact factor: 14.808

9.  The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation.

Authors:  M I Mackness; C Abbott; S Arrol; P N Durrington
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

10.  HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property.

Authors:  Guadalupe Ortiz-Muñoz; Xavier Houard; Jose-Luis Martín-Ventura; Brian Y Ishida; Stéphane Loyau; Patrick Rossignol; Juan-Antonio Moreno; John P Kane; Robert J Chalkley; Alma L Burlingame; Jean-Baptiste Michel; Olivier Meilhac
Journal:  FASEB J       Date:  2009-05-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.